SIBO Transmission and Causes

Introduction to SIBO

The American Gastroenterological Association suggests that SIBO is not contagious and cannot be transmitted from person to person, as it develops from an overgrowth of bacteria already present in the gastrointestinal tract 1, 2

Controlled studies demonstrate that no healthy controls tested positive for SIBO, indicating that it requires underlying predisposing factors rather than exposure to affected individuals 1, 2
Unlike true GI infections, SIBO does not require isolation precautions or contact avoidance, as stated by the American College of Gastroenterology 3

Impaired migrating myoelectric complex (MMC) prevents proper clearance of intestinal debris, creating gut stasis that allows bacterial proliferation, according to the European Society of Gastrointestinal Motility 4, 5
Reduced gastric acid, often from proton pump inhibitors, eliminates the normal acid barrier against bacterial overgrowth, as noted by the American College of Gastroenterology 5
Incompetent ileocecal valve allows colonic bacteria to reflux backward into the small intestine, as reported by the American Gastroenterological Association 6, 5
Altered intestinal motility from conditions like diabetes with autonomic neuropathy, medications, or surgical changes can contribute to SIBO development, as stated by the European Society of Gastrointestinal Motility 5

Prior abdominal surgery, particularly resection of the ileocecal valve or procedures altering normal anatomy, can increase the risk of SIBO, according to the American College of Surgeons 1, 2, 5
Pancreatic insufficiency reduces bacteriostatic pancreatic secretions, occurring in up to 92% of chronic pancreatitis patients with exocrine insufficiency, as reported by the American Pancreatic Association 1, 2, 5
Impaired local intestinal immunity affecting immunoglobulin secretion can also contribute to SIBO development, as noted by the European Society of Gastrointestinal Immunity 5

The American College of Gastroenterology recommends addressing underlying motility or anatomic issues plus antibiotic therapy (typically rifaximin 550mg twice daily for 1-2 weeks) for SIBO management, rather than isolation or infection control measures 4, 7
While SIBO itself is not contagious, true GI infections that may occur in immunosuppressed patients are transmissible and require appropriate precautions, as stated by the Centers for Disease Control and Prevention 3